Eligibility of patients with type 2 diabetes for sodium-glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study
型糖尿病患者参与钠-葡萄糖协同转运蛋白 2 抑制剂心血管结局试验的资格：来自 DISCOVER 研究的全球视角
期刊:Bmj Open Diabetes Research & Care
影响因子:4.1
doi:10.1136/bmjdrc-2018-000627
Pintat, Stéphane; Fenici, Peter; Hammar, Niklas; Ji, Linong; Khunti, Kamlesh; Medina, Jesús; Tang, Fengming; Wittbrodt, Eric; Surmont, Filip
